B. Kumar et al, WJPBT, 2015, 2(2): 22–33 World Journal of Pharmacy and Biotechnolo World Jou Journal Ho Research Article A Study on Clinical Manifesta Lupus Erythematosus Patient K. Durga Prasanna Roja, B. Kuma Department of Pharmacy Practice, Ratnam A B S T R A C T Systemic lupus erythematosus (SLE) is an a by tissue-binding auto antibodies and imm diversity of clinical manifestations. Patients drugs like steroids, immunosuppressant’s et patients according to EULAR are infection mellitus, osteoporosis, avascular necrosis o Tertiary care Hospital, Nellore during Octo enrolled into the study based on the inclusi presented in table 1. The mean age of 93 pa males (15:1.9) with an average age of 29.3 figure 1. 8.6% of the patients had a family patient’s hypertension was seen in 6.5% foll Keywords: SLE, EULAR, MRD, Co-morbi A R T I C L E I N F O CONTENTS 1. Introduction . . . . . . . . . . . . . . . . . . 2. Materials and Methods. . . . . . . . . . 3. Results and Discussion. . . . . . . . . . 4. Conclusion. . . . . . . . . . . . . . . . . . . 5. References . . . . . . . . . . . . . . . . . . . Article History: Received 27 August 2015, Citation: B. Kumar, et al. A Study on Clinical M in Tertiary Care Hospital. W. J. Pharm. Biotech., Copyright© 2015 B. Kumar, et al. This is an op which permits unrestricted use, distribution and r *Corresponding Author B. Kumar Department of Pharmacy Practice, Ratnam Institute of Pharmacy, Pidathap Nellore, Andhra Pradesh, India-524346 Manuscript ID: WJPBT2822 ogy urnal of Pharmacy and Biotechnolog ome Page: www.pharmaresearchlibrary.com/wjpbt ations, Treatment Pattern and Outcom ts in Tertiary Care Hospital ar*, M. Gobinath Institute of Pharmacy, Pidathapolur, Nellore, Andhra Pr autoimmune disease in which organs and cells undergo d mune complexes. The treatment of SLE is highly indiv ts are treated according to the clinical manifestations the tc. The comorbidities which increase the risk of morbid ns, hypertension, dyslipidemia, atherosclerosis, coronary of bone, malignancies. One hundred and thirty two pati ober 2014- August 2015were collected from MRD. Amon ion and exclusion criteria. The demographic details of al atients was 30.60 ± 8.83 years. The study population consi 3±8.5 years at the onset of the disease. Gender wise dis y history of the SLE. Among the various co-morbid con lowed by hypothyroidism (5.4%). id. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5, Accepted 28 October 2015, Available Online 29 Decem Manifestations, Treatment Pattern and Outcome in Systemic Lu , 2015, 2(2): 22-33. pen-access article distributed under the terms of the Creative Com reproduction in any medium, provided the original work is prop polur, ISSN: 2349-9087 22 gy Open Access me in Systemic radesh, India-524346 damage initially mediated vidualized because of its ey develop with different dity and mortality in SLE y artery disease, diabetes ients with SLE treated at ng them 93 patients were ll patients admitted were isted of 87 females and 6 stribution is presented in nditions observed in SLE . . . . . . . . . . . . . . . . . 23 . . . . . . . . . . . . . . . . . 23 . . . . . . . . . . . . . . . . . 24 . . . . . . . . . . . . . . . . . .31 . . . . . . . . . . . . . . . . . 31 mber 2015 PAPER-QR CODE upus Erythematosus Patients mmons Attribution License, perly cited.